Impact of ¹8F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.

OBJECTIVE: The aim of this study was to evaluate the value of fluorine-18 (¹8F) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in the detection of recurrent medullary thyroid carcinoma (MTC) in patients with elevated calcitonin levels. METHODS: Thirty-three patients (nine men, 24 women; mean age: 50.3 ± 12 years) who were referred to undergo ¹8F-FDG PET/CT for restaging of MTC in patients with high calcitonin levels were included in this study. Five patients also had suspected lymph nodes detected by neck ultrasonography. The results of ¹8F-FDG PET/CT and clinical follow-up data were reviewed retrospectively. Histological analysis has been accepted as the gold standard in the confirmation of ¹8F-FDG PET/CT results. Patients were followed up for 45.6 ± 4.2 months. RESULTS: There were 14 negative and 19 positive scans for possible recurrence of MTC. In the positive scans, the possible recurrence sites were neck lymph nodes, thyroid bed, mediastinal lymph nodes, and the lung in 14, two, two, and one patient, respectively. Disease recurrence in 13 patients was confirmed histologically by surgical excision or fine-needle aspiration biopsy. In the remaining six patients, recurrence was excluded as it was reactive as a result of pathological examination. However, one patient had a negative scan, underwent neck lymph node excision after ¹8F-FDG PET/CT examination, and lymph node recurrence was detected histologically. According to these results, the sensitivity and specificity of PET/CT were calculated as 93 and 68%, respectively. According to the recommended calcitonin level by the American Thyroid Association (calcitonin levels higher than 150 pg/ml), sensitivity was calculated as 90%. Although the mean maximum standardized uptake values of the true-positive and false-positive groups were calculated as 4.72 ± 2.17 and 4.22 ± 1.02, respectively, the difference between the two groups was not statistically significant (P>0.05). CONCLUSION: PET/CT is a sensitive imaging tool in the detection of MTC recurrence, especially in patients with high calcitonin levels, and it gives additional information in one third of all patients on an average by detecting an occult disease or confirming findings of other imaging tools.

Clinical validation of technetium-99m MIBI-gated single-photon emission computed tomography (SPECT) for avoiding false positive results in patients with left bundle-branch block: comparison with stress-rest nongated SPECT.

BACKGROUND: Septal perfusion defects are common on myocardial perfusion single-photon emission computed tomography (SPECT) slices in patients with left bundle-branch block (LBBB) in the absence of coronary artery disease. HYPOTHESIS: The use of gated myocardial perfusion SPECT imaging in such patients should be clinically validated. The aims of this study were, therefore, to validate clinically the use of gated myocardial SPECT imaging to avoid false positive septal perfusion defects in patients with LBBB and to compare nongated and gated SPECT imaging techniques in the same patients in the same imaging session. METHODS: We performed stress-rest myocardial perfusion SPECT and resting gated SPECT using Technetium-99m MIBI in 25 patients with LBBB and in 6 control subjects. Stress-rest SPECT images and end-diastolic and end-systolic gated SPECT slices were assessed visually and quantitatively (septum/lateral wall count ratio). Coronary angiography was performed in 15 patients with LBBB and in all 6 control subjects. RESULTS: Stress-rest (nongated) SPECT slices and end-diastolic and end-systolic gated SPECT images were normal in all control subjects. Stress-rest (nongated) SPECT imaging revealed septal perfusion defect in 20 (11 reversible, 9 irreversible) patients with LBBB, whereas the figures were 15 and 5 for end-systolic and end-diastolic gated SPECT images, respectively. Coronary angiography results were normal in all control subjects and in 15 patients with LBBB. Quantitative analysis of gated SPECT images revealed no statistically significant difference between patients with LBBB and control subjects in end-diastolic mean septum/lateral wall count values (0.86 +/- 0.19 in LBBB vs. 0.98 +/- 0.15 in normal subjects, p > 0.05), but the difference was statistically significant for end-systolic, stress, and rest values (p < 0.001 for all). CONCLUSION: Gated SPECT imaging, particularly end-diastolic images, revealed fewer false positive results and thus can be used to avoid false positive septal perfusion defects commonly seen in stress-rest (nongated) myocardial perfusion SPECT in patients with LBBB.